Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.49 |
| ▸ | PGR | P06401 | 1/20 | 0.49 |
| ▸ | HTR1A | P08908 | 1/20 | 0.49 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.49 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.49 |
| ▸ | PDE4A | P27815 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | DRD3 | P35462 | 1/20 | 0.49 |
| ▸ | SNCA | P37840 | 1/20 | 0.49 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.48 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.48 |
| ▸ | ICMT | O60725 | 1/20 | 0.48 |
| ▸ | GMNN | O75496 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27407686 | 1.00 | MAPT (0.49) | MAPTPGRHTR1AADORA3PTGS1 | |
| SCHEMBL7930022 | 1.00 | MAPT (0.49) | MAPTPGRHTR1AADORA3PTGS1 | |
| SCHEMBL28575111 | 1.00 | MAPT (0.49) | MAPTPGRHTR1AADORA3PTGS1 | |
| SCHEMBL6463435 | 1.00 | MAPT (0.49) | MAPTPGRHTR1AADORA3PTGS1 | |
| SCHEMBL2236562 | 1.00 | MAPT (0.49) | MAPTPGRHTR1AADORA3PTGS1 | |
| SCHEMBL6028170 | 1.00 | MAPT (0.49) | MAPTPGRHTR1AADORA3PTGS1 | |
| SCHEMBL14759154 | 1.00 | MAPT (0.49) | MAPTPGRHTR1AADORA3PTGS1 | |
| SCHEMBL1071266 | 0.98 | MAPT (0.47) | MAPTPGRHTR1AADORA3PTGS1 | |
| SCHEMBL1071264 | 0.98 | MAPT (0.47) | MAPTPGRHTR1AADORA3PTGS1 | |
| SCHEMBL16653887 | 0.98 | MAPT (0.47) | MAPTPGRHTR1AADORA3PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3018116-B1 | VITAMIN K2 INTERMEDIATES | KAPPA BIOSCIENCE AS (NO) | 2020-10-28 | — | — | EP | disclosed |
| EP-3018116-B1 | VITAMIN K2 INTERMEDIATES | KAPPA BIOSCIENCE AS (NO) | 2020-10-28 | — | — | EP | disclosed |
| US-10472314-B2 | Process for the preparation of vitamin K2 | KAPPA BIOSCIENCE AS (NO) | 2019-11-12 | — | — | US | disclosed |
| US-10472314-B2 | Process for the preparation of vitamin K2 | KAPPA BIOSCIENCE AS (NO) | 2019-11-12 | — | — | US | disclosed |
| US-20170283354-A1 | PROCESS FOR THE PREPARATION OF VITAMIN K2 | KAPPA BIOSCIENCE AS (NO) | 2017-10-05 | — | — | US | disclosed |
| US-20170283354-A1 | PROCESS FOR THE PREPARATION OF VITAMIN K2 | KAPPA BIOSCIENCE AS (NO) | 2017-10-05 | — | — | US | disclosed |
| US-20170283354-A1 | PROCESS FOR THE PREPARATION OF VITAMIN K2 | KAPPA BIOSCIENCE AS (NO) | 2017-10-05 | — | — | US | disclosed |
| EP-3018116-A1 | VITAMIN K2 INTERMEDIATES | Kappa Bioscience As (NO) | 2016-05-11 | — | — | EP | disclosed |
| EP-3018116-A1 | VITAMIN K2 INTERMEDIATES | Kappa Bioscience As (NO) | 2016-05-11 | — | — | EP | disclosed |
| EP-2346806-B1 | PROCESS FOR THE PREPARATION OF VITAMIN K2 | KAPPA BIOSCIENCE AS (NO) | 2016-01-06 | — | — | EP | disclosed |
| US-9012693-B2 | Process for the preparation of vitamin K2 | KAPPA BIOSCIENCE AS (NO) | 2015-04-21 | — | — | US | disclosed |
| US-9012693-B2 | Process for the preparation of vitamin K2 | KAPPA BIOSCIENCE AS (NO) | 2015-04-21 | — | — | US | disclosed |
| WO-2011117324-A2 | PROCESS FOR THE PREPARATION OF VITAMIN K2 | KAPPA BIOSCIENCE AS (NO) | 2011-09-29 | — | — | WO | disclosed |
| WO-2011117324-A2 | PROCESS FOR THE PREPARATION OF VITAMIN K2 | KAPPA BIOSCIENCE AS (NO) | 2011-09-29 | — | — | WO | disclosed |
| US-20110207967-A1 | PROCESS FOR THE PREPARATION OF VITAMIN K2 | KAPPA BIOSCIENCE AS (NO) | 2011-08-25 | — | — | US | disclosed |
| US-20110207967-A1 | PROCESS FOR THE PREPARATION OF VITAMIN K2 | KAPPA BIOSCIENCE AS (NO) | 2011-08-25 | — | — | US | disclosed |
| US-20110207967-A1 | PROCESS FOR THE PREPARATION OF VITAMIN K2 | KAPPA BIOSCIENCE AS (NO) | 2011-08-25 | — | — | US | disclosed |
| WO-2010034999-A1 | CRYSTALLINE MENOQUINONE-7 (VITAMIN K2) | KAPPA BIOSCIENCE AS (NO) | 2010-04-01 | — | — | WO | disclosed |
| WO-2010034999-A1 | CRYSTALLINE MENOQUINONE-7 (VITAMIN K2) | KAPPA BIOSCIENCE AS (NO) | 2010-04-01 | — | — | WO | disclosed |
| WO-2010035000-A1 | PROCESS FOR THE PREPARATION OF VITAMIN K2 | KAPPA BIOSCIENCE AS (NO) | 2010-04-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10472314-B2 | Process for the preparation of vitamin K2 | PROC, VKORC1, VKORC1L1 | MAPT 4698/4885PGR 2256/4885HTR1A 4464/4885 |
| US-20170283354-A1 | PROCESS FOR THE PREPARATION OF VITAMIN K2 | PROC, VKORC1, VKORC1L1 | MAPT 4724/4885PGR 2164/4885HTR1A 4517/4885 |
| US-20110207967-A1 | PROCESS FOR THE PREPARATION OF VITAMIN K2 | PROC, VKORC1, VKORC1L1 | MAPT 4700/4885PGR 2120/4885HTR1A 4501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.